Molecular Psychiatry · 2021 · 73 citations · 28 references
MedicineInfectious DiseasesPsychiatryEpidemiologic MethodsEpidemiologyMental Health CareComorbidityHealth DisparitiesMental HealthMental IllnessPsychiatric EpidemiologySevere Mental IllnessCohort Study InvestigationComorbid Medical IllnessLinkage Of Death RecordsLogistic RegressionLogistic Regression AnalysisMental Health InequalitiesPhysical Health DisparitiesPhysical Health Inequalities
People with severe mental illness (SMI; including schizophrenia/psychosis, bipolar disorder (BD), major depressive disorder (MDD)) experience large disparities in physical health. Emerging evidence suggests this group experiences higher risks of infection and death from COVID-19, although the full extent of these disparities are not yet established. We investigated COVID-19 related infection, hospitalisation and mortality among people with SMI in the UK Biobank (UKB) cohort study. Overall, 447,296 participants from UKB (schizophrenia/psychosis = 1925, BD = 1483 and MDD = 41,448, non-SMI = 402,440) were linked with healthcare and death records. Multivariable logistic regression analysis was used to examine differences in COVID-19 outcomes by diagnosis, controlling for sociodemographic factors and comorbidities. In unadjusted analyses, higher odds of COVID-19 mortality were seen among people with schizophrenia/psychosis (odds ratio [OR] 4.84, 95% confidence interval [CI] 3.00-7.34), BD (OR 3.76, 95% CI 2.00-6.35), and MDD (OR 1.99, 95% CI 1.69-2.33) compared to people with no SMI. Higher odds of infection and hospitalisation were also seen across all SMI groups, particularly among people with schizophrenia/psychosis (OR 1.61, 95% CI 1.32-1.96; OR 3.47, 95% CI 2.47-4.72) and BD (OR 1.48, 95% CI 1.16-1.85; OR 3.31, 95% CI 2.22-4.73). In fully adjusted models, mortality and hospitalisation odds remained significantly higher among all SMI groups, though infection odds remained significantly higher only for MDD. People with schizophrenia/psychosis, BD and MDD have higher risks of COVID-19 infection, hospitalisation and mortality. Only a proportion of these disparities were accounted for by pre-existing demographic characteristics or comorbidities. Vaccination and preventive measures should be prioritised in these particularly vulnerable groups.
28
Anna Fry, Thomas J. Littlejohns, Cathie Sudlow et al. · American Journal of Epidemiology · 2017 · 4.2K citations · Full text
Christoph U. Correll, Marco Solmi, Nicola Veronese et al. · World Psychiatry · 2017 · 1.7K citations · Full text